CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

PTEN loss / mutation (HR+/HER2- breast)

Gene: PTEN · Type: loss

Indications: Breast cancer

SensitivityResistanceCIViC Context

FDA Sensitivity Assertions

DrugIndicationRecommendationFDA SourceLink
CapivasertibBreast cancerINDICATED
FDA Label
Label